Cargando…

Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment

Cervical reserve cells are epithelial progenitor cells that are pathologically evident as the origin of cervical cancer. Thus, investigating the characteristics of cervical reserve cells could yield insight into the features of cervical cancer stem cells (CSCs). In this study, we established a metho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Masakazu, Kawana, Kei, Adachi, Katsuyuki, Fujimoto, Asaha, Yoshida, Mitsuyo, Nakamura, Hiroe, Nishida, Haruka, Inoue, Tomoko, Taguchi, Ayumi, Ogishima, Juri, Eguchi, Satoko, Yamashita, Aki, Tomio, Kensuke, Wada-Hiraike, Osamu, Oda, Katsutoshi, Nagamatsu, Takeshi, Osuga, Yutaka, Fujii, Tomoyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522215/ https://www.ncbi.nlm.nih.gov/pubmed/28402962 http://dx.doi.org/10.18632/oncotarget.16783

Ejemplares similares

Intracellular signaling entropy can be a biomarker for predicting the development of cervical intraepithelial neoplasia
por: Sato, Masakazu, et al.
Publicado: (2017)

Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis
por: Fujimoto, Asaha, et al.
Publicado: (2016)

Spheroid cancer stem cells display reprogrammed metabolism and obtain energy by actively running the tricarboxylic acid (TCA) cycle
por: Sato, Masakazu, et al.
Publicado: (2016)

Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL
por: Nakamura, Hiroe, et al.
Publicado: (2018)

The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
por: Ogishima, Juri, et al.
Publicado: (2018)

Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor
por: Inoue, Tomoko, et al.
Publicado: (2016)

Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity
por: Yoshida, Mitsuyo, et al.
Publicado: (2018)

Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis
por: Yoshida, Mitsuyo, et al.
Publicado: (2016)

Cells with stem‐like properties are associated with the development of HPV18‐positive cervical cancer
por: Kusakabe, Misako, et al.
Publicado: (2022)

Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer
por: Nakamura, Hiroe, et al.
Publicado: (2016)

Multistate Markov Model to Predict the Prognosis of High-Risk Human Papillomavirus-Related Cervical Lesions
por: Taguchi, Ayumi, et al.
Publicado: (2020)

A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
por: Ikeda, Yuji, et al.
Publicado: (2021)

Studying leukemia stem cell properties and vulnerabilities with human iPSCs
por: Spyrou, Nikolaos, et al.
Publicado: (2020)

Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia
por: Baba, Satoshi, et al.
Publicado: (2020)

HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1γ in cervical malignancy
por: Seiki, Takayuki, et al.
Publicado: (2015)

Diseases of tissue stem cells: human iPSCs provide new clues
Publicado: (2011)

Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
por: Aotsuka, Aeri, et al.
Publicado: (2019)

Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases
por: Sanjurjo-Rodríguez, Clara, et al.
Publicado: (2020)

Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
por: Orzechowski, Marcin, et al.
Publicado: (2020)

Prognosis of high‐risk human papillomavirus‐related cervical lesions: A hidden Markov model analysis of a single‐center cohort in Japan
por: Ikesu, Ryo, et al.
Publicado: (2021)

The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method
por: Liu, Yajun, et al.
Publicado: (2012)

Differentiation of Mouse Induced Pluripotent Stem Cells (iPSCs) into Nucleus Pulposus-Like Cells In Vitro
por: Chen, Jun, et al.
Publicado: (2013)

Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons
por: Shum, Carole, et al.
Publicado: (2015)

 Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases 
por: Chuang, Katherine, et al.
Publicado: (2017)

Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations
por: Moradi, Sharif, et al.
Publicado: (2019)

Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
por: Orzechowski, Marcin, et al.
Publicado: (2021)

Differentiation of Human Induced Pluripotent Stem Cells (iPSCs)–derived Mesenchymal Progenitors into Chondrocytes
por: Khan, Nazir M., et al.
Publicado: (2023)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
por: Fields, Mark, et al.
Publicado: (2016)

Senescence-associated ultrastructural features of long-term cultures of induced pluripotent stem cells (iPSCs)
por: Colasuonno, Fiorella, et al.
Publicado: (2017)

Differentiation and Establishment of Dental Epithelial-Like Stem Cells Derived from Human ESCs and iPSCs
por: Kim, Gee-Hye, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
por: Trillhaase, Anja, et al.
Publicado: (2021)

Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening
por: Aboul-Soud, Mourad A. M., et al.
Publicado: (2021)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state
por: Wang, Yixuan, et al.
Publicado: (2018)

Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient
por: Lee, Han-Kyu, et al.
Publicado: (2016)

Aged induced pluripotent stem cell (iPSCs) as a new cellular model for studying premature aging
por: Petrini, Stefania, et al.
Publicado: (2017)

Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome
por: Sripathy, S.R., et al.
Publicado: (2020)

Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus
por: De Angelis, Maria Teresa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vjlqajj8m55gh09v7tbpp6dhnt